RT Journal Article
T1 Experience in Spain with the first patients in home hemodialysis treated with low-flow dialysate monitors.
T2 Experiencia en España con los primeros pacientes en hemodiálisis domiciliaria tratados con monitores de bajo flujo de líquido de diálisis.
A1 Slon Roblero, Maria Fernanda
A1 Bajo Rubio, Maria Auxiliadora
A1 González-Moya, Mercedes
A1 Calviño Varela, Jesús
A1 Pérez Alba, Alejandro
A1 Villaro Gumpert, Juan
A1 Cigarrán, Secundino
A1 Vidau, Pedro
A1 García Marcos, Sergio
A1 Abáigar Luquin, Pedro
A1 Coll Piera, Elisabet
A1 Gascón Mariño, Antonio
A1 Espigares, Maria José
A1 Molina, Mariola D
A1 Molina, Pablo
K1 Adecuación
K1 Adequacy
K1 Dializado de bajo flujo
K1 Hemodiálisis domiciliaria
K1 Hemodiálisis intensiva
K1 Home hemodialysis
K1 Intensive hemodialysis
K1 Lactate
K1 Lactato
K1 Low flow dialysate
AB Home hemodialysis (HHD) with low-flow dialysate devices has gained popularity in recent years due to its simple design, portability, and ability to provide greater freedom of movement for our patients. However, there are doubts about the adequacy that this technology offers, since it uses monitors with low-flow bath and lactate. The aim of this study was to demonstrate the clinical benefits of low-flow HHD with the NxStage System One® recently introduced in Spain. We present the results of an observational, retrospective cohort study that included the first patients who started short daily HHD with this device in 12 Spanish centers. We analyzed the evolution of 86 patients at 0, 6 and 12 months, including data related to prescription, and evolution of biochemical parameters related to dialysis dose, anemia, mineral-bone metabolism; evolution of residual renal function, medication usage, and causes of withdrawal during the followup. We were able to demonstrate that this NxStage System One® monitor, in patients with HHD, have provided an adequate dialysis dose, with optimal ultrafiltration rate, with improvement of main biochemical markers of dialysis adequacy. The usage of this technique was associated to a decrease of antihypertensive drugs, phosphate binders and erythropoietin agents, with very good results both patient and technique survival. The simplicity of the technique, together with its good clinical outcomes, should facilitate the growth and utilization of HHD, both in incident and prevalent patients.
YR 2021
FD 2021-08-12
LK http://hdl.handle.net/10668/22415
UL http://hdl.handle.net/10668/22415
LA en
LA es
DS RISalud
RD Apr 19, 2025